Globally, the COVID-19 pandemic has had extreme consequences for the healthcare system
and has led to calls for diagnostic tools to monitor and understand the transmission …

Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infections often cause only
mild disease that may evoke relatively low Ab titers compared with patients admitted to …

Background Almost 2 years from the beginning of the coronavirus disease 2019 (COVID-19)
pandemic, there is still a lot unknown how the humoral response affects disease …

COVID-19 caused by SARS-CoV-2 infection has caused substantial morbidity and mortality
worldwide and paralyzed the international economy. Understanding the magnitude and …

Background Monitoring the adaptive immune responses during the natural course of severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection provides useful …

In December 2019, the novel betacoronavirus Severe Acute Respiratory Disease
Coronavirus 2 (SARS-CoV-2) was first detected in Wuhan, China. SARS-CoV-2 has since …

The humoral immune response to SARS-CoV-2 is a benchmark for immunity and detailed
analysis is required to understand the manifestation and progression of COVID-19, monitor …

A new coronavirus, SARS-CoV-2, has recently emerged to cause a human pandemic.
Whereas molecular diagnostic tests were rapidly developed, serologic assays are still …

Abstract Development of antibody protection during SARS-CoV-2 infection is a pressing
question for public health and for vaccine development. We developed highly sensitive …

SARS‐CoV‐2 has emerged as a human pathogen, causing clinical signs, from fever to
pneumonia—COVID‐19—but may remain mild or asymptomatic. To understand the …